Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Pat PurcellMeeting Engagement
Stacey GandlerBrand Nourishment
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
- Company expediting planned dose escalation activities - - Low levels of SGT-001 microdystrophin ...
Intratumoral injections of INT230-6 were well tolerated with no drug-related serious adverse events or ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email